154 related articles for article (PubMed ID: 37178784)
1. Treatment of Adolescent Endometriosis Before, During, and After Use of Gonadotropin-Releasing Hormone Agonists: A Retrospective Cohort Study.
Shim JY; Laufer MR; DiVasta AD
J Pediatr Adolesc Gynecol; 2023 Oct; 36(5):472-475. PubMed ID: 37178784
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Effects of Gonadotropin-Releasing Hormone Agonists and Add-Back in Adolescent Endometriosis.
Gallagher JS; Missmer SA; Hornstein MD; Laufer MR; Gordon CM; DiVasta AD
J Pediatr Adolesc Gynecol; 2018 Aug; 31(4):376-381. PubMed ID: 29551430
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial.
Sadler Gallagher J; Feldman HA; Stokes NA; Laufer MR; Hornstein MD; Gordon CM; DiVasta AD
J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):215-222. PubMed ID: 26927501
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
Surrey ES
Curr Opin Obstet Gynecol; 2010 Aug; 22(4):283-8. PubMed ID: 20498596
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy.
Soliman AM; Bonafede M; Farr AM; Castelli-Haley J; Winkel C
J Manag Care Spec Pharm; 2016 May; 22(5):573-87. PubMed ID: 27123918
[TBL] [Abstract][Full Text] [Related]
6. Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
DiVasta AD; Feldman HA; Sadler Gallagher J; Stokes NA; Laufer MR; Hornstein MD; Gordon CM
Obstet Gynecol; 2015 Sep; 126(3):617-627. PubMed ID: 26181088
[TBL] [Abstract][Full Text] [Related]
7. The use of gonadotropin releasing hormone analogues in adolescent and young patients with endometriosis.
DiVasta AD; Laufer MR
Curr Opin Obstet Gynecol; 2013 Aug; 25(4):287-92. PubMed ID: 23770813
[TBL] [Abstract][Full Text] [Related]
8. Oral continuous combined 0.5 mg estradiol valerate and 5 mg dydrogesterone as daily add-back therapy during post-operative GnRH agonist treatment for endometriosis in Chinese women.
Zou S; Long Q; Zhang S; Han Y; Zhang W
Int J Clin Exp Med; 2013; 6(1):67-73. PubMed ID: 23236560
[TBL] [Abstract][Full Text] [Related]
9. Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.
Bedaiwy MA; Allaire C; Alfaraj S
Fertil Steril; 2017 Mar; 107(3):537-548. PubMed ID: 28139239
[TBL] [Abstract][Full Text] [Related]
10. [Management of painful endometriosis in adolescents: CNGOF-HAS Endometriosis Guidelines].
Sauvan M; Chabbert-Buffet N; Geoffron S; Legendre G; Wattier JM; Fernandez H
Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):264-266. PubMed ID: 29519595
[TBL] [Abstract][Full Text] [Related]
11. Decreased Level of Neurotrophic Factor Neuritin 1 in Women with Ovarian Endometriosis after Receiving Gonadotropin-Releasing Hormone Agonist Treatment.
Rahmawati E; Yang WV; Lei YP; Maurya PK; Chen HW; Tzeng CR
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491902
[TBL] [Abstract][Full Text] [Related]
12. Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence.
Lee DY; Bae DS; Yoon BK; Choi D
Hum Reprod; 2010 Dec; 25(12):3050-4. PubMed ID: 20937741
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis.
Kim NY; Ryoo U; Lee DY; Kim MJ; Yoon BK; Choi D
Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):85-9. PubMed ID: 20832162
[TBL] [Abstract][Full Text] [Related]
14. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
Surrey ES; Judd HL
J Clin Endocrinol Metab; 1992 Aug; 75(2):558-63. PubMed ID: 1386374
[TBL] [Abstract][Full Text] [Related]
15. [The role of the combined balneotherapeutic treatment as the 'add-back therapy' against the background of the anti-hormonal effects of the agonists of gonadotropin-releasing hormone in the women suffering from endometriosis genitalis externa].
Akhkubekova NK; Kaysinova AS; Fedorov AA; Efimenko NB; Gaidamaka II; Chalaja EN; Cherevashchenko LA; Tsallagova LV; Urvacheva EE; Ovsienko AB
Vopr Kurortol Fizioter Lech Fiz Kult; 2018; 95(5):31-39. PubMed ID: 30412147
[TBL] [Abstract][Full Text] [Related]
16. Effects of add-back therapy on bone mineral density and pyridinium crosslinks in patients with endometriosis treated with gonadotropin-releasing hormone agonists.
Gnoth CH; Gödtke K; Freundl G; Godehardt E; Kienle E
Gynecol Obstet Invest; 1999; 47(1):37-41. PubMed ID: 9852390
[TBL] [Abstract][Full Text] [Related]
17. Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A; Puscasiu L; Vollenhoven B
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
[TBL] [Abstract][Full Text] [Related]
18. The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis.
Chwalisz K; Surrey E; Stanczyk FZ
Reprod Sci; 2012 Jun; 19(6):563-71. PubMed ID: 22457429
[TBL] [Abstract][Full Text] [Related]
19. The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial.
Guo H; Du T; Gao H; Xi Q; Wu L; Lyu Q; Zhu Q
Reprod Health; 2022 Oct; 19(1):198. PubMed ID: 36195878
[TBL] [Abstract][Full Text] [Related]
20. Maintenance Therapy for Preventing Endometrioma Recurrence after Endometriosis Resection Surgery - A Systematic Review and Network Meta-analysis.
Chiu CC; Hsu TF; Jiang LY; Chan IS; Shih YC; Chang YH; Wang PH; Chen YJ
J Minim Invasive Gynecol; 2022 May; 29(5):602-612. PubMed ID: 35123042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
